Search Results - "Chard Dunmall, Louisa S."
-
1
Natural products targeting glycolysis in cancer
Published in Frontiers in pharmacology (01-11-2022)“…Many energy metabolism pathways exist in cancer, including glycolysis, amino acid metabolism, fatty acid oxidation, and mitochondrial respiration. Tumor cells…”
Get full text
Journal Article -
2
Characterization of the Intra-tumoral B Cell Immunoglobulin Repertoire Is of Prognostic Value for Esophageal Squamous Cell Carcinoma
Published in Frontiers in immunology (22-06-2022)“…Esophageal Squamous Cell carcinomas (ESCC) is a highly heterogeneous malignancy that is among the leading cause of cancer-related death worldwide. B cells play…”
Get full text
Journal Article -
3
Ferroptosis-Related Genes Are Potential Therapeutic Targets and the Model of These Genes Influences Overall Survival of NSCLC Patients
Published in Cells (Basel, Switzerland) (15-07-2022)“…Background: Lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSCC) are two of the most common subtypes of non-small cell lung cancer (NSCLC), with…”
Get full text
Journal Article -
4
An effective therapeutic regime for treatment of glioma using oncolytic vaccinia virus expressing IL-21 in combination with immune checkpoint inhibition
Published in Molecular therapy. Oncolytics (15-09-2022)“…Glioblastoma (GBM) is the most common primary malignant tumor in the brain, accounting for 51.4% of all primary brain tumors. GBM has a highly…”
Get full text
Journal Article -
5
A systemically deliverable Vaccinia virus with increased capacity for intertumoral and intratumoral spread effectively treats pancreatic cancer
Published in Journal for immunotherapy of cancer (01-01-2021)“…BackgroundPancreatic cancer remains one of the most lethal cancers and is refractory to immunotherapeutic interventions. Oncolytic viruses are a promising new…”
Get full text
Journal Article -
6
A novel vaccinia virus enhances anti-tumor efficacy and promotes a long-term anti-tumor response in a murine model of colorectal cancer
Published in Molecular therapy. Oncolytics (26-03-2021)“…Colorectal cancer (CRC) is one of the leading causes of mortality and morbidity in the world, and there remains an urgent need to develop long-lasting…”
Get full text
Journal Article -
7
Redirecting anti-Vaccinia virus T cell immunity for cancer treatment by AAV-mediated delivery of the VV B8R gene
Published in Molecular therapy. Oncolytics (16-06-2022)“…Immunotherapies, such as immune checkpoint inhibitors (ICIs) and chimeric antigen receptor-T (CAR-T) cells, are only efficient in a small proportion of tumor…”
Get full text
Journal Article -
8
Remodeling the tumor microenvironment by oncolytic viruses: beyond oncolysis of tumor cells for cancer treatment
Published in Journal for immunotherapy of cancer (01-05-2022)“…Tumor cells manipulate the local environment in which they grow, creating a tumor microenvironment (TME) that promotes tumor survival and metastasis. The TME…”
Get full text
Journal Article -
9
Transient Inhibition of PI3Kδ Enhances the Therapeutic Effect of Intravenous Delivery of Oncolytic Vaccinia Virus
Published in Molecular therapy (06-05-2020)“…Tumor-targeting oncolytic viruses such as vaccinia virus (VV) are attractive cancer therapeutic agents that act through multiple mechanisms to provoke both…”
Get full text
Journal Article -
10
A novel microenvironment regulated system CAR-T (MRS.CAR-T) for immunotherapeutic treatment of esophageal squamous carcinoma
Published in Cancer letters (01-08-2023)“…Chimeric antigen receptor T cell immunotherapy has achieved promising therapeutic effects in the treatment of hematological malignancies. However, there are…”
Get full text
Journal Article -
11
Syrian hamster as an ideal animal model for evaluation of cancer immunotherapy
Published in Frontiers in immunology (27-02-2023)“…Cancer immunotherapy (CIT) has emerged as an exciting new pillar of cancer treatment. Although benefits have been achieved in individual patients, the overall…”
Get full text
Journal Article -
12
Promising xenograft animal model recapitulating the features of human pancreatic cancer
Published in World journal of gastroenterology : WJG (28-08-2020)“…Multiple sites of metastasis and desmoplastic reactions in the stroma are key features of human pancreatic cancer (PC). There are currently no simple and…”
Get full text
Journal Article -
13
The integrated molecular and histological analysis defines subtypes of esophageal squamous cell carcinoma
Published in Nature communications (18-10-2024)“…Esophageal squamous cell carcinoma (ESCC) is highly heterogeneous. Our understanding of full molecular and immune landscape of ESCC remains limited, hindering…”
Get full text
Journal Article -
14
The capability of heterogeneous γδ T cells in cancer treatment
Published in Frontiers in immunology (2023)“…γδ T cells, a specialized subset of T lymphocytes, have garnered significant attention within the realm of cancer immunotherapy. Operating at the nexus between…”
Get full text
Journal Article -
15
MHC class II molecules on pancreatic cancer cells indicate a potential for neo-antigen-based immunotherapy
Published in Oncoimmunology (31-12-2022)“…MHC class II expression is a hallmark of professional antigen-presenting cells and key to the induction of CD4+ T helper cells. We found that these molecules…”
Get full text
Journal Article -
16
Optimized Anchor-Modified Peptides Targeting Mutated RAS Are Promising Candidates for Immunotherapy
Published in Frontiers in immunology (26-05-2022)“…RAS mutations occur in approximately 20% of all cancers and given their clonality, key role as driver mutation, association with poor prognosis and…”
Get full text
Journal Article -
17
Personalized neoantigen viro-immunotherapy platform for triple-negative breast cancer
Published in Journal for immunotherapy of cancer (01-08-2023)“…Triple-negative breast cancer (TNBC) corresponds to approximately 20% of all breast tumors, with a high propensity for metastasis and a poor prognosis. Because…”
Get full text
Journal Article -
18
Treatment and Prevention of Lung Cancer Using a Virus-Infected Reprogrammed Somatic Cell-Derived Tumor Cell Vaccination (VIReST) Regime
Published in Frontiers in immunology (13-08-2020)“…Lung cancer is one of the most commonly diagnosed cancer and despite therapeutic advances, mortality remains high. The long period of clinical latency…”
Get full text
Journal Article -
19
A Tumor-Targeted Replicating Oncolytic Adenovirus Ad-TD-nsIL12 as a Promising Therapeutic Agent for Human Esophageal Squamous Cell Carcinoma
Published in Cells (Basel, Switzerland) (10-11-2020)“…Esophageal squamous cell carcinoma (ESCC) is one of the most lethal cancers in China and existing therapies have been unable to significantly improve…”
Get full text
Journal Article